Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares were down 13.8% during trading on Thursday . The stock traded as low as $12.21 and last traded at $12.21. Approximately 300 shares traded hands during trading, a decline of 87% from the average daily volume of 2,323 shares. The stock had previously closed at $14.17.
Shionogi & Co., Ltd. Price Performance
The stock has a 50-day moving average price of $13.15 and a two-hundred day moving average price of $29.35.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
See Also
- Five stocks we like better than Shionogi & Co., Ltd.
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What is the Australian Securities Exchange (ASX)
- Top 3 ETFs to Hedge Against Inflation in 2025
- Short Selling: How to Short a Stock
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
